Giovanna Finzi

Giovanna Finzi

Auto-generated profile, based on publicly available information

Giovanna Finzi

Unit of Pathology, ASST dei Sette Laghi, Varese, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Neurochemistry International
Verified
Journal Article
Open access
MZMara Zilocchi
Mara Zilocchi
GFGiovanna Finzi
Giovanna Finzi
Marta LualdiMarta Lualdi
Marta Lualdi
FSFausto Sessa
Fausto Sessa
Mauro FasanoMauro Fasano
Mauro Fasano
TATiziana Alberio
Tiziana Alberio
Mitochondrial impairment is one of the most important hallmarks of Parkinson's disease (PD) pathogenesis. In this work, we wanted to verify the molecular basis of altered mitochondrial dynamics and disposal in Substantia nigra specimens of sporadic PD patients, by the comparison with two cellular models of PD. Indeed, SH-SY5Y cells were treated with either dopamine or 1-methyl-4-phenylpyridinium (MPP+) in order to highlight the effect of altered dopamine homeostasis and of complex I inhibition, respectively. As a result, we found that fusion impairment of the inner mitochondrial membrane is a common feature of both PD human samples and cellular models. However, the effects of dopamine and MPP+ treatments resulted to be different in terms of the mitochondrial damage induced. Opposite changes in the levels of two mitochondrial protein markers (voltage-dependent anion channels (VDACs) and cytochrome c oxidase subunit 5β (COX5β)) were observed. In this case, dopamine treatment better recapitulated the molecular picture of patients' samples. Moreover, the accumulation of PTEN-induced putative kinase 1 (PINK1), a mitophagy marker, was not observed in both PD patients samples and cellular models. Eventually, in transmission electron microscopy images, small electron dense deposits were observed in mitochondria of PD subjects, which are uniquely reproduced in dopamine-treated cells. In conclusion, our study suggests that the mitochondrial molecular landscape of Substantia nigra specimens of PD patients can be mirrored by the impaired dopamine homeostasis cellular model, thus supporting the hypothesis that alterations in this process could be a crucial pathogenetic event in PD.

31 March 2023 in Science Advances
Verified
Journal Article
Open access
RSRajendran Sanalkumar
Rajendran Sanalkumar
RDRui Dong
Rui Dong
LLLukuo Lee
Lukuo Lee
YXYu-Hang Xing
Yu-Hang Xing
SISowmya Iyer
Sowmya Iyer
NRNicolò Riggi
Nicolò Riggi
Cell fate transitions observed in embryonic development involve changes in three-dimensional genomic organization that provide proper lineage specification. Whether similar events occur within tumor cells and contribute to cancer evolution remains largely unexplored. We modeled this process in the pediatric cancer Ewing sarcoma and investigated high-resolution looping and large-scale nuclear conformation changes associated with the oncogenic fusion protein EWS-FLI1. We show that chromatin interactions in tumor cells are dominated by highly connected looping hubs centered on EWS-FLI1 binding sites, which directly control the activity of linked enhancers and promoters to establish oncogenic expression programs. Conversely, EWS-FLI1 depletion led to the disassembly of these looping networks and a widespread nuclear reorganization through the establishment of new looping patterns and large-scale compartment configuration matching those observed in mesenchymal stem cells, a candidate Ewing sarcoma progenitor. Our data demonstrate that major architectural features of nuclear organization in cancer cells can depend on single oncogenes and are readily reversed to reestablish latent differentiation programs.

30 May 2023 in Endocrine Pathology
Verified
Journal Article
Closed access
ASAmedeo Sciarra
Amedeo Sciarra
SUSilvia Uccella
Silvia Uccella
PHPhilippe Hiroz
Philippe Hiroz
IFIan Fournier
Ian Fournier
VSVincent Soubeyran
Vincent Soubeyran
SRStefano La Rosa
Stefano La Rosa

10 March 2011 in Endocrine Pathology
Verified
Journal Article
Closed access
PDF file
SRStefano La Rosa
Stefano La Rosa
AMAlessandro Marando
Alessandro Marando
FGFabio Ghezzi
Fabio Ghezzi
PCPaolo Colombo
Paolo Colombo
GFGiovanna Finzi
Giovanna Finzi
CCCarlo Capella
Carlo Capella

27 October 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
ACAlessandro De Carli
Alessandro De Carli
CFCarolina Filipponi
Carolina Filipponi
BPBeatrice Polini
Beatrice Polini
VSVeronica Sancho-Bornez
Veronica Sancho-Bornez
EBEmy Basso
Emy Basso
GDGiuseppe Daniele
Giuseppe Daniele
Diabetes-associated neurodegeneration is amplified by methylglyoxal (MGO)-driven dicarbonyl stress linking hyperglycemia to neuronal insulin resistance and

24 September 2026 in Virchows Archiv
Verified
Journal Article
Open access
PDF file
SRStefano La Rosa
Stefano La Rosa
FBFederica Branca
Federica Branca
GFGiovanna Finzi
Giovanna Finzi
LLLaura Libera
Laura Libera
MLMonica Leutner
Monica Leutner
Abbas AgaimyAbbas Agaimy
Abbas Agaimy
We report the clinical, morphological, ultrastructural, and molecular features of a gastroblastoma diagnosed in a 27-year-old male describing some unreported findings that can help to better understand this very rare tumor. The clinical course lasting 28 years confirms the indolent nature of gastroblastoma, although the disease was metastatic to local lymph nodes and peritoneum at the time of diagnosis. The tumor displayed a predominant monophasic appearance, being composed of epithelial cells with only very rare spindle mesenchymal cells, confirmed at ultrastructural examination. Thorough immunohistochemical investigation demonstrated coexpression of cytokeratins (AE1/AE3, CAM5.2, CK8/18), podoplanin (D2-40), CD56, and NSE in absence of synaptophysin, chromogranin A, DOG1, CD117, CD34, SMA, desmin, vimentin, and S100. In addition, the expression of somatostatin receptor 2 A associated with positive octreoscan and 68Ga-DOTATOC PET imaging may suggest the use of this nuclear medicine approach for the staging of the tumor and to select patients for possible therapy with somatostatin analogues. The tumor was mismatch repair proteins proficient and did not show any mutation in all 60 genes investigated. Interestingly, targeted RNA sequencing identified a previously unreported TAC3::GLI1 fusion that expands the spectrum of genetic aberrations of gastroblastoma.